Doiphode Avani R, Kalaskar Ritesh, Kalaskar Ashita, Honaje Nilam V, Gala Urvi P
Department of Pediatric and Preventive Dentistry, Government Dental College and Hospital, Nagpur, Maharashtra, India.
Department of Oral Medicine and Radiology, Government Dental College and Hospital, Nagpur, Maharashtra, India.
Int J Clin Pediatr Dent. 2024 Sep;17(9):1075-1085. doi: 10.5005/jp-journals-10005-2947.
To evaluate the effectiveness of low-level laser therapy (LLLT) as a pulpotomy agent in primary molars.
This systematic review followed the recommendation of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline 2020.
An electronic search of the databases was performed to find the effectiveness of LLLT over formocresol as a pulpotomy agent in primary molars in children aged between 3 and 10 years.
Authors independently extracted the data from the 14 included studies based on the inclusion criteria. The inclusion criteria comprised studies that compared the clinical and radiographical effectiveness of LLLT pulpotomy with formocresol pulpotomy in primary molars using randomized clinical trials (RCTs).
The risk of bias was assessed using a tool developed by the Cochrane Collaboration for RCT studies.
The meta-analyses were performed using the fixed-effects model. Heterogeneity was assessed by a Q test and quantified with I statistics. Radiological and clinical success among the teeth treated with either formocresol or LLLT was considered the main outcome.
The search resulted in 390 published studies. After the removal of duplicate studies and analysis of full-text articles, 14 studies were selected for systematic review. Overall, the results demonstrated a high risk of selection and performance bias. No statistically significant difference was found between LLLT and formocresol as pulpotomy agents when compared clinically and radiographically at 6-9 and 12-month follow-up periods. LLLT is a good alternative method to be used as a pulpotomy agent in cases of reversible pulpitis.
Low-level laser therapy is an emerging and trending branch in dentistry because of its beneficial effects in various treatment approaches. It can be effectively used in the pulpotomy procedure due to its properties to reduce pulp inflammation, improve healing, and preserve dental pulp vitality.
Doiphode AR, Kalaskar R, Kalaskar A, Clinical and Radiographic Efficacy of Low-level Laser Therapy and Formocresol as Pulpotomy Agents in Primary Molars: A Systematic Review and Meta-analysis. Int J Clin Pediatr Dent 2024;17(9):1075-1085.
评估低强度激光疗法(LLLT)作为乳磨牙牙髓切断术药物的有效性。
本系统评价遵循了《系统评价和Meta分析的首选报告项目》(PRISMA)2020指南的建议。
对数据库进行电子检索,以找出LLLT相对于甲醛甲酚作为3至10岁儿童乳磨牙牙髓切断术药物的有效性。
作者根据纳入标准从14项纳入研究中独立提取数据。纳入标准包括使用随机临床试验(RCT)比较LLLT牙髓切断术与甲醛甲酚牙髓切断术在乳磨牙中的临床和影像学有效性的研究。
使用Cochrane协作网为RCT研究开发的工具评估偏倚风险。
采用固定效应模型进行Meta分析。通过Q检验评估异质性,并用I统计量进行量化。用甲醛甲酚或LLLT治疗的牙齿的影像学和临床成功率被视为主要结果。
检索得到390篇已发表的研究。在去除重复研究并分析全文后,选择了14项研究进行系统评价。总体而言,结果显示存在较高的选择和实施偏倚风险。在6至9个月和12个月的随访期进行临床和影像学比较时,LLLT和甲醛甲酚作为牙髓切断术药物之间未发现统计学上的显著差异。LLLT是可逆性牙髓炎病例中用作牙髓切断术药物的一种良好替代方法。
低强度激光疗法因其在各种治疗方法中的有益作用,是牙科领域一个新兴且热门的分支。由于其具有减轻牙髓炎症、促进愈合和保持牙髓活力的特性,它可有效地用于牙髓切断术。
Doiphode AR, Kalaskar R, Kalaskar A, 低强度激光疗法和甲醛甲酚作为乳磨牙牙髓切断术药物的临床和影像学疗效:系统评价和Meta分析。《国际临床儿科牙科学杂志》2024;17(9):1075 - 1085。